These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37215985)

  • 1. Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer.
    Chen YM; Xu W; Liu Y; Zhang JH; Yang YY; Wang ZW; Sun DJ; Li H; Liu B; Chen LX
    Int J Biol Sci; 2023; 19(8):2531-2550. PubMed ID: 37215985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Withanolides from
    Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer.
    Takatani-Nakase T; Ikushima C; Sakitani M; Nakase I
    Life Sci; 2024 Feb; 339():122411. PubMed ID: 38184272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
    Wang Y; Pang X; Liu Y; Mu G; Wang Q
    Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
    Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
    Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
    J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
    Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
    Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WTAP Mediates NUPR1 Regulation of LCN2 Through m
    Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
    Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
    Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
    J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitavastatin induces autophagy-dependent ferroptosis in MDA-MB-231 cells via the mevalonate pathway.
    Tang WJ; Xu D; Liang MX; Wo GQ; Chen WQ; Tang JH; Zhang W
    Heliyon; 2024 Mar; 10(5):e27084. PubMed ID: 38444467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib.
    Song X; Wang X; Liu Z; Yu Z
    Front Oncol; 2020; 10():597434. PubMed ID: 33425751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of NO Donor-Aurovertin Hybrids as Dual Ferroptosis and Apoptosis Inducers for Treating Triple Negative Breast Cancer.
    Ma LF; Xu LL; Yuan LJ; Yang X; Wu R; Bao SM; Chen YL; Duan HL; Fang L; Zhao HJ; Zhan ZJ
    J Med Chem; 2024 Aug; 67(15):13089-13105. PubMed ID: 39044437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
    Mokhtarpour K; Razi S; Rezaei N
    Breast Cancer Res Treat; 2024 Oct; 207(3):497-513. PubMed ID: 38874688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrastigma hemsleyanum polysaccharide combined with doxorubicin promote ferroptosis and immune function in triple-negative breast cancer.
    Shang Y; Zhao M; Chen S; Chen Y; Liu X; Zhou F; Li Y; Long M; Xu K; Ding Z; Wang L
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133424. PubMed ID: 38945330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
    Li J; He D; Li S; Xiao J; Zhu Z
    Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
    Wang Y; Sun Y; Wang F; Wang H; Hu J
    Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
    Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
    Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth.
    Zhao H; Zhang M; Zhang J; Sun Z; Zhang W; Dong W; Cheng C; Yao Y; Li K
    Cell Biosci; 2023 May; 13(1):87. PubMed ID: 37179385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Mitochondria-Targeted Ferroptosis Inducer Activated by Glutathione-Responsive Imaging and Depletion for Triple Negative Breast Cancer Theranostics.
    Gan H; Huang X; Luo X; Li J; Mo B; Cheng L; Shu Q; Du Z; Tang H; Sun W; Wang L; Luo S; Yu S
    Adv Healthc Mater; 2023 Sep; 12(22):e2300220. PubMed ID: 37204240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting AKT induced Ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer.
    Zhang G; Mi W; Wang C; Li J; Zhang Y; Liu N; Jiang M; Jia G; Wang F; Yang G; Zhang L; Wang J; Fu Y; Zhang Y
    Cell Death Discov; 2023 Dec; 9(1):457. PubMed ID: 38102129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.